J. Goldman & CO LP Heron Therapeutics, Inc. Transaction History

J. Goldman & CO LP

  • $3.21 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$2.25 - $4.67 $721,266 - $1.5 Million
-320,563 Reduced 85.58%
54,000 $135,000
Q3 2022

Nov 14, 2022
BUY
$2.66 - $5.37 $996,337 - $2.01 Million
374,563 New
374,563 $1.58 Million
Q1 2018

May 15, 2018
SELL
$18.43 - $28.8 $1.2 Million - $1.88 Million
-65,263 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$14.8 - $18.85 $965,892 - $1.23 Million
65,263
65,263 $1.18 Million

Others Institutions Holding HRTX

# of Institutions
180
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $133M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email